BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Drug Product News
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014
FDA Warning: PML Death Associated With Biogen Idec (BIIB)'s Tecfidera 11/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Docetaxel Injection USP 11/24/2014
Perrigo Company (PRGO) Announces The Launch Of A Generic Version Of Astellas' Protopic Ointment 0.1% And 0.03% 11/24/2014
Sanofi (SAN.PA) Aims To Launch 18 New Drugs By 2020 11/21/2014
ViaDerma Lead Product TetraStem Shows Promise in Treating Acne 11/21/2014
IntelliPharmaCeutics Notes Launch Of 5mg Strength Of Focalin XR(R) Generic By Teva Pharmaceutical Industries Limited (TEVA) 11/20/2014
Endo International plc (ENDP) Announces Launch Of Generic Version Of Valcyte 11/20/2014
Amneal Pharmaceuticals Launches AG For Novo Nordisk A/S (NVO)’s Activella® 11/20/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Over-The-Counter Fexofenadine Hydrochloride 60 Mg And Pseudoephedrine Hydrochloride 120 Mg Extended-Release Tablets 11/20/2014
Keryx Biopharmaceuticals (KERX) Announces Trade Name Auryxia for Ferric Citrate 11/19/2014
AstraZeneca PLC (AZN) Shows Off Strong Drug Pipeline As Pfizer (PFE) Deadline Looms 11/18/2014
Pfizer (PFE) Release: TRUMENBA® (Meningococcal Group B Vaccine) Is Now Available 11/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches Liquid Formulation Of TREANDA® (bendamustine HCI) Injection In U.S. 11/18/2014
Organovo Announces Commercial Release Of The exVive3D™ Human Liver Tissue 11/18/2014
Peli Biothermal Coolpall Vertos Launch Success In Europe 11/18/2014
Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex/ 11/18/2014
Galderma Laboratories Release: The Cetaphil® Brand Revamps RestoraDerm® Product Line 11/17/2014
Mallinckrodt Pharmaceuticals (MNK)'s Generic ADHD Drug Does Not Measure Up To Johnson & Johnson (JNJ)'s Concerta: FDA 11/14/2014
Mallinckrodt Pharmaceuticals (MNK) Responds To FDA’s Expected Reclassification Of Methylphenidate ER 11/14/2014
Kremers Urban Pharmaceuticals Inc. Informed By U.S. FDA Of ANDA Reclassification Of Methylphenidate ER 11/14/2014
Hep C King Gilead Sciences, Inc. (GILD)'s Harvoni Prescriptions Are Breaking Records 11/13/2014
Major Medical Centers Ask Congress To Probe Genentech (RHHBY)'s Distribution Changes 11/13/2014
Novartis AG (NVS) To Deliver Three Million Malaria Treatments For Kids In Zambia 11/13/2014
Five Percent Of Medicines In Malaysia Are Counterfeit: Pfizer (PFE) 11/11/2014
Oculus Innovative Sciences, Inc. (OCLS) Commercializes Microcyn®-Based Solution And Hydrogel For Treatment Of Mild-To-Moderate Acne In Europe 11/11/2014
Babies Die While Officials Haggle With Novartis AG (NVS) Over Cost Of Bexsero Vaccine 11/11/2014
Afaxys Pharmaceuticals Announces Wider National Availability Of ella® Emergency Contraceptive 11/11/2014
Endo Pharmaceuticals (ENDP) Receives Final Approval For Generic Version Of Valcyte® 11/10/2014
Eli Lilly (LLY)'s Trulicity™ (dulaglutide) Now Available In U.S. Pharmacies 11/10/2014
Tetrastem, Lead Product Of ViaDerma, Hopes To Slow Rates Of Diabetic Amputations 11/7/2014
ANI Pharmaceuticals, Inc. Announces The Launch Of Methazolamide Tablets USP 11/6/2014
Hospira, Inc. Announces U.S. Launch of Generic Paricalcitol Injection 11/6/2014
Mylan Inc. (MYL) Launches Generic Loestrin 24 Fe® 11/5/2014
Ranbaxy Laboratories (RANBAXY.BO) Receives Approval From FDA To Market Fenofibrate Capsules USP, 43 mg And 130 mg 11/5/2014
McNeil-PPC, Inc. Release: First FDA-Approved, Once Daily Application 5% Minoxidil Formula For Women Hits The Market 11/4/2014
Inergetics, Inc.' OmEssentials® Supplements Line Available At Whole Foods This Fall 11/4/2014
BioDelivery Sciences International (BDSI) Announces The Availability Of BUNAVAIL™ In The U.S. 11/3/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Novel Topical Treatment For Erectile Dysfunction In Belgium By Sandoz, Inc. 11/3/2014
Pharming Group (PHGUF.PK) And Salix Pharmaceuticals, Ltd. (SLXP) Announce The Launch Of Ruconest® In The U.S. For The Treatment Of Acute Angioedema Attacks In Patients With Hereditary Angioedema (HAE) 11/3/2014
Express Scripts Inc. Says AbbVie (ABBV)'s Drug Could Displace Gilead Sciences, Inc. (GILD)'s Sovaldi On Formulary 10/31/2014
Migranade, Inc. Release: Game Changing Migraine Medication To Be Available November 2014 10/31/2014
When Will Biosimilars Impact The U.S. Market? 10/30/2014
Omeros Corporation (OMER) Release: Omidria™ Granted Pass-Through Reimbursement Status From CMS 10/30/2014
Mylan Inc. (MYL) Launches Generic Viramune XR® 10/30/2014
Novo Nordisk A/S (NVO) Announces U.S. Launch Of NovoFine® Plus, A New Pen Needle For Patients With Diabetes 10/29/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Sirolimus Tablets, 1 mg And 2 mg 10/29/2014
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/28/2014
Fresenius Kabi AG Launches Kabiven® In The United States 10/27/2014
Octapharma AG Announces Octagam® 10% Now Available For Ordering In U.S. 10/27/2014
Pelvalon Announces New Analysis From The LIFE Pivotal Trial At The 2014 ICS Conference And Unveils The Brand Name For Its Vaginal Bowel Control Therapy 10/24/2014
European Medicines Agency Completes Review Of Polymyxin-Based Medicines 10/24/2014
BioSpace’s Favorite FDA Tricks Or Treats 10/24/2014
FDA Release: Gilead Sciences, Inc. (GILD)'s Harvoni® (ledipasvir/sofosbuvir) Approved For The Treatment Of Chronic Hepatitis C, Genotype 1 Infection In Adults; Diplomat To Distribute 10/23/2014
Tekmira (TKMR) Provides Periodic Update On TKM-Ebola Program 10/22/2014
Gilead Sciences, Inc. (GILD)'s $1,000-A-Pill Hepatitis C Drug May Make Financial Sense For Prisons 10/21/2014
Boehringer Ingelheim Pharmaceuticals, Inc. Release: OFEV® (nintedanib) Now Available In The United States 10/21/2014
Government Of Canada Ships NewLink Genetics' Ebola Vaccine To The WHO 10/20/2014
U.S. Regulators Ask Three Labs For Mapp Biopharmaceutical's ZMapp Ebola Plans 10/20/2014
Takeda Pharmaceuticals And Orexigen Therapeutics, Inc. (OREX) Announce Availability Of CONTRAVE® (naltrexone HCI And bupropion HCI) Extended-Release Tablets For Chronic Weight Management In Obese Adults 10/20/2014
Baxter International, Inc. (BAX) Launches HYQVIA In The United States For Adult Patients With Primary Immunodeficiency 10/20/2014
Admedus Cardiocel® To Be Launched In Canada 10/20/2014
Gilead Sciences, Inc. (GILD) Nervous As Johnson & Johnson (JNJ) Looks To Remain Competitive In Hepatitis C Market 10/16/2014
Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials 10/16/2014
Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg 10/14/2014
Chimerix, Inc. (CMRX) Slips As Ebola Patient On Brincidofovir Dies 10/13/2014
PuraMed BioScience Nears Completion Of A Hemp-Derived-Cannabinoid-Based Non-Prescription Medication For Treatment Of Epilepsy Symptoms 10/13/2014
Health Canada Release: Safety Information On The Risk Of Blood Clots With Immunoglobulin Products 10/13/2014
Orexo AB (ORXOF) Submits Application To FDA For Expanded Label Of ZUBSOLV® 10/13/2014
Purdue Pharma L.P. Commercially Launches Recently Approved 7.5 Mcg/Hour Dosage Strength Of Butrans® (Buprenorphine) Transdermal System CIII 10/9/2014
Fujifilm Diosynth Biotechnologies Announces The Launch Of Its ‘Apollo™’ Mammalian Expression Platform 10/9/2014
Gilead Sciences, Inc. (GILD)'s Solvadi May Be Barred From UK's Service Plan 10/9/2014
Boehringer Ingelheim Corporation Release: New COPD Maintenance Treatment Striverdi® Respimat® (olodaterol) Inhalation Spray Now Available in U.S. Pharmacies 10/8/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To Patients Infected With Ebola Virus 10/6/2014
Mylan Inc. (MYL) Launches Generic Combivir® 10/6/2014
Medac Pharma, Inc.'s Rasuvo (methotrexate) Injection Now Available For Patients With Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis And Psoriasis 10/6/2014
Ashland Inc.  (ASH) Announces Global Price Increase For Vinyl Pyrrolidone- And Cellulosic-Based Pharmaceutical Excipient Products 10/6/2014
AstraZeneca PLC (AZN) Release: BRILINTA Preferred Over Clopidogrel In 2014 American Heart Association/American College of Cardiology Guideline For The Management Of Non–ST-Elevation Acute Coronary Syndromes 10/6/2014
National Institute for Clinical Excellence (NICE) Rejects Another Roche (RHHBY) Leukemia Drug Citing Data Uncertainties 10/6/2014
Diploma PLC (DPLM.L) Release: Otezla® (apremilast) Receives Expanded Indication; Diplomat To Distribute 10/2/2014
Ranbaxy Laboratories (RANBAXY.BO) Launches ABSORICA® (isotretinoin) 25 Mg And 35 Mg Capsules In The U.S. Market 10/1/2014
Prollenium Medical Technologies Release: Lyracaine Topical Anesthetic Now Approved For Sale In Canada 10/1/2014
Pfizer (PFE) Starts New Viagra Commercials Targeting Women 9/30/2014
Mapp Biopharmaceutical's Ebola Drug Production Set for Texas, Possibly North Carolina 9/30/2014
Inergetics, Inc. Introduces Surgex® Warrior Sports Nutrition At Winn-Dixie 9/30/2014
LEO Pharma Announced New Taclonex® (Calcipotriene And Betamethasone Dipropionate) Topical Suspension, 0.005%/0.064% Indication For Treatment Of Scalp Plaque Psoriasis In Pediatric Patients Ages 12-17 9/30/2014
Par Pharmaceutical, Inc. Begins Shipment of Generic Exforge® 9/30/2014
Janssen-Cilag International NV (JNJ) Release: CHMP Announces Positive Opinion For REZOLSTA™, A New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir And Cobicistat 9/29/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Available for the 2014/2015 Influenza Season 9/29/2014
Jaguar Animal Health, Inc. Launches First Product, Neonorm™ Calf, At World Dairy Expo 9/29/2014
Actavis (ACT) Will Keep Selling Alzheimer's Drug In U.S. For 60 Days 9/26/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To A French Woman Infected With Ebola Virus 9/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Levalbuterol Inhalation Solution, USP 9/24/2014
Sagent Pharmaceuticals, Inc. Announces The Introduction Of Oxaliplatin Injection, USP 9/24/2014
Regeneron Pharmaceuticals, Inc. (REGN) R&D Chief Reveals Allergy Drug May Be Darling Of Its Pipeline 9/23/2014
Anacor Pharmaceuticals, Inc. (ANAC) Announces Commercial Launch Of KERYDIN (tavaborole) Topical Solution, 5% In The United States 9/23/2014
Lannett Company, Inc. (LCI) Launches Oxycodone Hydrochloride Oral Solution 9/22/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved For The European Union 9/22/2014
60 Percent Of New York’s Hep C Patients Will Get Gilead Sciences, Inc. (GILD)'s Sovaldi 9/19/2014
Sagent Pharmaceuticals, Inc. Announces The Launch Of Ketorolac Tromethamine Injection, USP 9/18/2014
Roche (RHHBY) Introduces A New Fertility Test For Assessment Of Ovarian Reserve For Pregnancy 9/18/2014
Janssen Pharmaceutical Inc. Release: Prezcobix™ Now Available For Canadians Living With HIV 9/17/2014
New Product From Vireo Systems: pH-D Feminine Health Support 9/17/2014
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System 9/16/2014
Bayer HealthCare (BAY) Announces The Launch Of Aleve® PM: The First And Only OTC PM Pain Reliever With A Sleep Aid Plus The 12-Hour Pain Relieving Strength Of Aleve 9/15/2014
Easton Pharmaceuticals (OP: EAPH) Announces Preparations For North American Product(s) Launch 9/15/2014
Roche (RHHBY) Battles Counterfeit Rituxin Vials In Germany 9/15/2014
The Medicines Company (MDCO) To Review ORBACTIV™ (Oritavancin) Launch Readiness On Tuesday, September 16, 2014 9/12/2014
The Obesity Society Release: New FDA-Approved Weight Loss Drug Adds New Tool For Obesity Treatment 9/11/2014
EMD Serono Canada Inc. Announces Launch Of The Eeva® Test In Canada 9/11/2014
Regeneus (RGS.AX) Kvax Cancer Vaccine Available In Australia, U.S. Trial Begins 9/11/2014
Cerilliant Corporation Snap-N-Spike® | Snap-N-Shoot® Certified Reference Materials Now Available Through Sigma-Aldrich Corporation (SIAL) 9/10/2014
Marathon Pharmaceuticals, LLC Launches Zingo® (Lidocaine Hydrochloride Monohydrate) Powder Intradermal Injection System, Topical Local Anesthetic To Manage Venous Access Pain 9/9/2014
Theravance, Inc. (THRX) Provides VIBATIV® (telavancin) Product Update 9/9/2014
National Institute for Clinical Excellence (NICE) Rejects Celgene (CELG)'s Abraxane For Pancreatic Cancer Over Limited Benefits, Cost 9/9/2014
Sagent Pharmaceuticals, Inc. Announces The Launch Of Ibandronate Sodium Injection 9/8/2014
Endo International plc (ENDP) Announces Launch Of Authorized Generic Of FORTESTA® Gel 9/8/2014
AstraZeneca PLC (AZN) Release: BYDUREON® Pen, A Treatment Option For Adults With Type 2 Diabetes, Now Available In Pharmacies 9/8/2014
Silvergate Pharmaceuticals Release: FDA Approves 2 New Indications For Epaned®, The First And Only Enalapril Powder For Oral Solution 9/8/2014
UK Watchdog Backs Alexion Pharmaceuticals Inc. (ALXN)'s "Very Expensive" Drug Soliris 9/5/2014
Genzyme Corporation (GENZ)'s New Rare Disease Pill Will Cost Patients $310,250 A Year 9/5/2014
Mylan Inc. (MYL) Launches Generic Boniva® Injection 9/5/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Baraclude® Tablets, 0.5mg And 1mg, In The United States 9/4/2014
National Institute for Clinical Excellence (NICE) Recommends Commissioning Of Eculizumab (Soliris®) For All Patients With aHUS In England 9/4/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches SYNCare™ Home Administration Support Program For Patients On SYNRIBO® (Omacetaxine Mepesuccinate) For Injection 9/3/2014
Procter & Gamble (PG) Release: Vicks® Breaks Into Allergy And Sinus Category With The Introduction Of Qlearquil™ 9/3/2014
Iroko Pharmaceuticals Announces Inclusion Of ZORVOLEX® In Key 2015 National Formularies 9/3/2014
Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden 9/2/2014
Lundbeck Inc. (LUN.CO) Announces Availability Of NORTHERA™ (droxidopa) Capsules In The U.S. For Symptomatic Neurogenic Orthostatic Hypotension 9/2/2014
BioTie Therapies Corp.: Selincro Enters The Market In Germany 8/29/2014
Janssen Research & Development Expands EXPLORER Global Cardiovascular Research Program To Evaluate The Role Of XARELTO® In Addressing Critical Medical Needs 8/29/2014
BBI Solutions Launches A Fully Validated Human Recombinant Cystatin C Antigen 8/27/2014
TNI BioTech Announces First Shipment Of Lodonal® To The Republic Of Panama And The Republic Of Malawi 8/27/2014
Ipsen (IPN.PA) Announces Second Resupply Of Increlex® (Mecasermin [Rdna Origin] Injection) In The U.S. In 2014 8/26/2014
Eli Lilly and Company (LLY) Release: New Type 2 Diabetes Treatment Jardiance® (empagliflozin) Tablets For Adults Now Available In U.S. Pharmacies 8/26/2014
Fera Pharmaceuticals Announces Launch of Moxatag® Authorized Generic 8/25/2014
Mylan Inc. (MYL) Launches First Generic Klor-Con® Extended-Release Tablets 8/22/2014
Pfizer Inc. (PFE) Release: Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With Hr+, Her2- Advanced Breast Cancer 8/21/2014
Telomere Biosciences LLC Announces: TELO-20 For Dogs, The World's First Telomere-Lengthening Supplement For Dogs, To Promote Healthy Aging And Longevity 8/21/2014
Lannett Company, Inc. (LCI) Comments On Utilization Of Digoxin 8/20/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Will Be Available At Over 230 Passport Health Locations Nationwide 8/19/2014
Mylan Inc. (MYL) Launches Generic Precedex™ Injection - Another Key Product Approval 8/19/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In Germany By Hexal 8/18/2014
Fresenius Kabi AG Introduces Acetylcysteine Solution 10% In 4 Ml, 10 Ml And 30 Ml Vials 8/18/2014
National Institute for Clinical Excellence (NICE) And Johnson & Johnson (JNJ) Urged To End Zytiga Fiasco 8/15/2014
Pragma Pharmaceuticals Announces Re-Launch of Moxatag® 8/15/2014
U.S. Panel Says Seniors Should Get Pfizer Inc. (PFE)'s Prevnar 13 8/14/2014
PuraMed BioScience Completes the First Production of MigraPure® Gel 8/14/2014
Merck & Co., Inc. (MRK) Statement Regarding Role Of PNEUMOVAX® 23 (Pneumococcal Vaccine Polyvalent) In Updated ACIP Recommendations For Pneumococcal Vaccination In Adults 8/14/2014
Amneal Pharmaceuticals Announces Four New Generics 8/13/2014
Sanofi US (SNY) Launches Authorized Generic Version Of Eloxatin® (oxaliplatin Injection) 8/12/2014
Sanofi (France) (SAN.PA), PATH Roll Out First Large-Scale Batches Of Antimalarial Drug 8/12/2014
Another Controversial High Price Med: National Institute for Clinical Excellence (NICE) Rejects Roche (RHHBY)'s New $152,850 Breast Cancer Drug 8/11/2014
Mylan Inc. (MYL) Launches Generic Xeloda® Tablets 8/11/2014
Fresenius Kabi AG Release: Diprivan® (Propofol) Injectable Emulsion, USP Now Available In 10 Ml Vials 8/11/2014
BTG plc (BTG.L) Release: First Varicose Vein Patient Treated With FDA-Approved Varithena® (polidocanol Injectable Foam) 1% 8/11/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Launch Of ADASUVE® (Inhalation Powder, loxapine) In Guatemala 8/8/2014
NextSource Biotechnology Gains FDA Approval For Use Of Tradename Gleostine™ (Lomustine), An Anti-Cancer Chemotherapy Agent 8/8/2014
Suneva Medical's Regenica® Skin Care System Gets New Look 8/8/2014
A Little Drug From Questcor Pharmaceuticals, Inc. (QCOR) Generates Controversy And A $220 Million Medicare Bill 8/7/2014
Merck & Co., Inc. (MRK) Concerned For Diabetes Patients In Canada As Top Drugs Are Cut From Program 8/6/2014
Sagent Pharmaceuticals, Inc. Announces The Reintroduction Of Irinotecan Hydrochloride Injection, USP 8/5/2014
Cubist Pharmaceuticals, Inc. (CBST)’s Once-Daily SIVEXTRO™ (Tedizolid Phosphate) Available For Physician And Hospital Order In I.V. And Oral Formulations 8/5/2014
bioCSL Inc. Launches AFLURIA® Shipping Campaign For 2014-2015 Seasonal Influenza 8/5/2014
Gilead Sciences, Inc. (GILD) Battles To Shift Debate Over $1,000 Hepatitis Pills From Costs To Cures 8/5/2014
Troubled GlaxoSmithKline (GSK) Gets A Lift As Express Scripts Inc. Reinstates Lung Drug Advair 8/5/2014
Blow To Amgen (AMGN)'s Profits As Express Scripts Inc. Drops Drugs From List Of Preferred Drugs 8/4/2014
Tekmira Pharmaceuticals Corporation (TKMR) Says Ebola Drug Not Used To Treat U.S. Aid Workers 8/4/2014
Eli Lilly and Company (LLY) Release: Type 2 Diabetes: Jentadueto® (linagliptin and metformin hydrochloride) Tablets Label Updated To Include New Data On Blood Glucose Reductions In Treatment-Naive Adults With High Baseline A1C 8/4/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In Sweden By Sandoz, Inc. 8/4/2014
Certara Corporation Launches D360 In Japan To Improve Drug Discovery And Development Productivity 8/4/2014
Chiesi Farmaceutici SpA And uniQure Provide Update On Glybera® Launch 8/4/2014
PuraMed BioScience Rebrands Its Natural Migraine Relief Medication, Lipigesic M 7/31/2014
BioPharm Executive: Have Drugs Finally Been Priced Too High? 7/31/2014
GlaxoSmithKline (GSK)'s Tanzeum™ Is Now Available In Pharmacies In The U.S. 7/30/2014
INNOPHARMA Announces Launch Of Olanzapine For Injection, 10mg/Vial In Canada 7/30/2014
AstraZeneca PLC (AZN) Fights With Pediatrician Group Over Preemie Drug Guidelines 7/29/2014
Akrimax Pharmaceuticals Initiates CONTROL Patient Registry For Tirosint® (Levothyroxine Sodium) Capsules 7/29/2014
Perrigo Company (PRGO) Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 7/28/2014
The Upsher-Smith Laboratories Galaxy™ Portfolio Of Antiepileptic Drugs Now Available 7/28/2014
Boehringer Ingelheim Corporation Release: Benefits And Safety Of Pradaxa® (Dabigatran Etexilate Mesylate) Repeatedly Confirmed 7/24/2014
Abbott Introduces New Similac® Breastfeeding Supplement With DHA, Lutein And Vitamin E 7/24/2014
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States 7/24/2014
Daiichi Sankyo, Inc. (4568.t) And Eli Lilly and Company (LLY): Heart Patients In England And Wales Offered More Choice Of Therapies As National Institute for Clinical Excellence (NICE) Extends Recommendations For Prasugrel 7/23/2014
Third Product In Vernalis PLC (VNLPY.PK)’ Cough Cold Pipeline (CCP-08) Achieves Proof-Of-Concept 7/22/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
BioTie Therapies Corp.: Selincro Enters The Market In Spain 7/22/2014
Sanofi Pasteur (SASY.PA) Begins Shipping Seasonal Influenza Vaccine For Upcoming 2014-2015 Season In United States 7/22/2014
Shire Release: Firazyr®: First Subcutaneous Treatment For Acute Attacks Of Rare And Serious Swelling Disorder Now Available In Canada 7/21/2014
BioAlliance Pharma Announces The Launch Of Sitavig® In The United States By Its Partner Innocutis 7/21/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
Durata Therapeutics, Inc.  (DRTX) Announces The U.S. Launch Of Dalvance™ 7/18/2014
MediGene AG (MDGEF.PK)'s Drug Veregen® Launched In Canada 7/17/2014
NovaBay Pharmaceuticals, Inc. (NBY) Announces Direct US Marketing-Sales Campaign For New i-Lid™ Cleanser Product 7/16/2014
Celsion Corporation (CLN) Announces Commercialization Of Reagent Products 7/15/2014
Bial And moksha8 Announce Exclusive License For The Commercialization Of Eslicarbazepine Acetate (Zebinix® / Exalief®) In Brazil And Mexico 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
Upsher-Smith Laboratories Announces Immediate Availability Of A Generic Equivalent To Qudexy™ XR (Topiramate) Extended-Release Capsules 7/14/2014
BioTie Therapies Corp.: Selincro Receives Positive Draft Guidance From UK's National Institute for Clinical Excellence (NICE) 7/10/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014